Carregant...
Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy
No effective treatment for COVID-19 has been well established yet. Nafamostat, known as anticoagulant, has potential anti-inflammatory and anti-viral activities against COVID-19. We report three cases of COVID-19 pneumonia who progressed while using antiviral drugs and needed supplementary oxygen th...
Guardat en:
| Publicat a: | Int J Infect Dis |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7250091/ https://ncbi.nlm.nih.gov/pubmed/32470602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2020.05.072 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|